Renal Function After CT-Guided Cryoablation of Small Renal Tumours in Patients with Solitary Kidney: An Analysis of European Multinational Prospective EuRECA Registry.
Cryoablation
Image-guided
Renal cell carcinoma
Renal function
Renal masses
Solitary kidney
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
25 Jan 2024
25 Jan 2024
Historique:
received:
08
05
2023
accepted:
22
11
2023
medline:
26
1
2024
pubmed:
26
1
2024
entrez:
25
1
2024
Statut:
aheadofprint
Résumé
Treatment of renal cell carcinoma (RCC) in patients with solitary kidneys remains challenging. The purpose of this multicentre cohort study was to explore how renal function is affected by percutaneous image-guided cryoablation in patients with solitary kidneys. Data from the European Registry for Renal Cryoablation database were extracted on patients with RCC in solitary kidneys treated with image-guided, percutaneous cryoablation. Patients were excluded if they had multiple tumours, had received previous treatment of the tumour, or were treated with more than one cryoablation procedure. Pre- and post-treatment eGFR (within 3 months of the procedure) were compared. Of 222 patients with solitary kidneys entered into the database, a total of 70 patients met inclusion criteria. The mean baseline eGFR was 55.8 ± 16.8 mL/min/1.73 m Image-guided renal cryoablation appears to be safe and effective for renal function preservation in patients with RCC in a solitary kidney. Following cryoablation, all patients had preservation of renal function without the need for dialysis or progression in chronic kidney disease stage despite the statistically significant reduction in eGFR. LEVEL OF EVIDENCE 3: Observational study.
Identifiants
pubmed: 38273129
doi: 10.1007/s00270-023-03634-4
pii: 10.1007/s00270-023-03634-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74–84.
doi: 10.1016/j.eururo.2018.08.036
pubmed: 30243799
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.
doi: 10.1016/j.ejca.2018.07.005
pubmed: 30100160
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
doi: 10.3322/caac.21660
pubmed: 33538338
Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82(4):399–410.
doi: 10.1016/j.eururo.2022.03.006
pubmed: 35346519
Deng W, Chen L, Wang Y, Liu X, Wang G, Liu W, et al. cryoablation versus partial nephrectomy for clinical stage T1 renal masses: a systematic review and meta-analysis. J Cancer. 2019;10(5):1226–36.
doi: 10.7150/jca.28881
pubmed: 30854132
pmcid: 6400682
Pessoa RR, Autorino R, Laguna MP, Molina WR, Gustafson D, Nogueira L, et al. Laparoscopic versus percutaneous cryoablation of small renal mass: systematic review and cumulative analysis of comparative studies. Clin Genitourin Cancer. 2017;15(5):513–9.
doi: 10.1016/j.clgc.2017.02.003
pubmed: 28442227
Chan VW, Abul A, Osman FH, Ng HH, Wang K, Yuan Y, et al. Ablative therapies versus partial nephrectomy for small renal masses—a systematic review and meta-analysis. Int J Surg. 2022;97:106194.
doi: 10.1016/j.ijsu.2021.106194
pubmed: 34958968
Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(5):706–20.
doi: 10.1093/annonc/mdz056
pubmed: 30788497
Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198(3):520–9.
doi: 10.1016/j.juro.2017.04.100
pubmed: 28479239
(AUA) AUA. AUA. AUA guidelines update: renal mass AUA annual meeting, New Orleans. LA2022, 2022. Available from: https://www.urotoday.com/conference-highlights/2022-annual-meeting/aua-2022-kidney-cancer/137164-aua-2022-aua-guidelines-update-renal-mass.html
Rod X, Peyronnet B, Seisen T, Pradere B, Gomez FD, Verhoest G, et al. Impact of ischaemia time on renal function after partial nephrectomy: a systematic review. BJU Int. 2016;118(5):692–705.
doi: 10.1111/bju.13580
pubmed: 27409986
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting of observational studies. Internist. 2008;49(6):688–93.
doi: 10.1007/s00108-008-2138-4
Group ERC. European registry for renal cryoablation 2011 Available from: https://www.eureca-registry.com/Public/Home.aspx
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
doi: 10.1016/0021-9681(87)90171-8
pubmed: 3558716
Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844–53.
doi: 10.1016/j.juro.2009.05.035
pubmed: 19616235
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
Ljungberg B, Albiges L, Bensalah K, Vex A, Giles RH, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Powles T, Staehler M, Volpe A. EAU guidelines in renal cell carcinoma. Eur Assoc Urol. 2020
Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69(1):116–28.
doi: 10.1016/j.eururo.2015.03.027
pubmed: 25819723
Pickersgill NA, Vetter JM, Kim EH, Cope SJ, Du K, Venkatesh R, et al. Ten-year experience with percutaneous cryoablation of renal tumors: tumor size predicts disease progression. J Endourol. 2020;34(12):1211–7.
doi: 10.1089/end.2019.0882
pubmed: 32292059
Bhindi B, Mason RJ, Haddad MM, Boorjian SA, Leibovich BC, Atwell TD, et al. Outcomes after cryoablation versus partial nephrectomy for sporadic renal tumors in a solitary kidney: a propensity score analysis. Eur Urol. 2018;73(2):254–9.
doi: 10.1016/j.eururo.2017.09.009
pubmed: 28967553
Mir MC, Capitanio U, Bertolo R, Ouzaid I, Salagierski M, Kriegmair M, et al. Role of active surveillance for localized small renal masses. Eur Urol Oncol. 2018;1(3):177–87.
doi: 10.1016/j.euo.2018.05.001
pubmed: 31102618
Junker T, Duus L, Rasmussen BSB, Azawi N, Lund L, Graumann O, et al. Quality of life and complications after nephron-sparing treatment of renal cell carcinoma stage T1—a systematic review. Syst Rev. 2022;11(1):4.
doi: 10.1186/s13643-021-01868-2
pubmed: 34983648
pmcid: 8725354
Junker T, Duus L, Rasmussen BSB, Azawi N, Lund L, Norgaard B, et al. Impact of partial nephrectomy and percutaneous cryoablation on short-term health-related quality of life—a prospective comparative cohort study. Eur Urol Open Sci. 2022;45:99–107.
doi: 10.1016/j.euros.2022.09.013
pubmed: 36353658
pmcid: 9637566
Neves JB, Warren H, Santiapillai J, Rode N, Cullen D, Pavlou M, et al. Nephron sparing treatment (NEST) for small renal masses: a feasibility cohort-embedded randomised controlled trial comparing percutaneous cryoablation and robot-assisted partial nephrectomy. Eur Urol. 2023.